PUBLICAÇÕES científicas

Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin B12 and folic acid supplementation for advanced non-small cell lung cancer.

Joaquim Bosch-Barrera (a), Miren Gaztañaga (a), Jaime Ceballos (a), José L. Pérez-Gracia [ES] (a), José M. López-Picazo [ES] (a), Jesús García-Foncillas (a), Marta Ferrer (b), María L. Sanz [ES] (b), Maider Pretel (c), Miguel A. Idoate [ES] (d), Ignacio Gil-Bazo (a)
(a) Department of Oncology
(b) Department of Allergy and Clinical Immunology
(c) Department of Dermatology
(d) Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain

Revisão:Onkologie

Data: 1/Out/2009

Alergologia e Imunologia Clínica Dermatologia Oncologia Médica Anatomia Patológica [ES]

BACKGROUND
Pemetrexed is a multitargeted antifolate initially approved as a single agent for the second-line treatment of locally advanced or metastatic non-small cell lung cancer and more recently in the first-line setting combined with cisplatin. The combination of pemetrexed with carboplatin has been tested in several phase II clinical trials showing interesting antitumour activity with mild toxicity. Supplementation with folic acid and vitamin B12 during treatment with pemetrexed is recommended to reduce potential haematological and gastrointestinal adverse events.

CASE REPORT
A patient experienced cutaneous lesions including widespread erythema, epidermal detachment, and skin denudation, associated with deterioration of his general condition after the second cycle of this chemotherapy combination, which was clinically and histologically compatible with toxic epidermal necrolysis (Lyell's syndrome). Treatment with systemic steroids, antihistamines, and antibiotics led to resolution of the skin lesions and improvement of his general condition.

CONCLUSION
To our knowledge, this is the second case reported in the literature of this type of suspected adverse drug reaction associated with a pemetrexed-based chemotherapy combination.

CITAÇÃO DO ARTIGO  Onkologie. 2009 Oct;32(10):580-4

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra